Abstract:Synthesised a sequence of structurally related copper(II) complexes of Schiff base ligands, 2-[(2-benzylamino-ethylimino)-methyl]-phenol [L1(H)], 2-[(2-benzylamino-ethylimino)-methyl]-4-methyl-phenol [L2(H)], 2-[(2-benzylamino-ethylimino)-methyl]-4-bromo-phenol [L3(H)]. The complexes were characterized by ATR, UV-Vis, EPR, ESI-MS, single crystal XRD, and elemental analysis. Based on the crystal structure, ligand was coordinated to the copper(II) centre in a tridentate mode through phenolate(oxygen), imine nitrogen and amine nitrogen in a NNO fashion and the azide moiety served as an auxiliary ligand. Further, we have investigated the microbial activities of copper(II) complexes against clinically relevant fungal strains including Candida albicans, Candida glabrata, and Candida tropicalis, as well as bacteria such as Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA), representing Gram-negative and Gram-positive pathogenic strains. Considering the activity of complex 2 (128-512 μg/mL) to complex 3 (64-128 μg/mL), the latter demonstrated more potent effectiveness against all of the tested fungal strains. The activity of the complexes against MRSA reveals the inhibitory concentrations for 1 (1024 μg/mL), 2 (128 μg/mL), and 3 (256 μg/mL. It is worth mentioning that, at their minimum inhibitory concentrations (MICs), the complexes are not toxic to Galleria mellonella. Furthermore, the spot and broth microdilution assay results were in good agreement with the actual metabolic viability of bacterial and fungal strains, in which the complexes were active while having no effect on the metabolite resazurin. Additionally, in silico studies have been employed to elucidate both non-bonding interactions and the mode of action across protein sequences of experimentally studied microbes. The performance of complexes closely mirrored the reactivity order determined in in vitro studies. The impeding property of complexes can be due to the dysfunctioning of virulent genes, signalling proteins, and also affects the activities of transferase and transcriptase proteins. Overall, the complexes are promising candidates for antimicrobial drug development. We anticipate utilising these molecules for clinical purposes.

Cu(II)-3-aminoacetanilide complex: Synthesis and antibacterial activity test

Synthesis, characterization and antibacterial test of Tetrakis(3-Aminophenol) Copper(II)Nitrate Hexahydrate

Diaquachloro-tris(ethyl-p-Aminobenzoate)copper(II) Chloride: Synthesis, Characterization and In Vitro Investigation of Antibacterial Activity

SYNTHESIS, CHARACTERIZATION OF COPPER(II) COMPLEX WITH TETRADENTATE N2O2 AND POTENTIAL CONTRIBUTION AS PROMISING ANTIBACTERIAL STUDIES

Synthesis, characterization and antibacterial activity of copper(ii) and nickel(ii) complexes with 3, 10-dialkyl-1, 3, 5, 8, 10, 12 hexaazacyclotetradecane ligand

Anion Induced Synthesis and Crystal Structures of Schiff Base Copper(II) and Zinc(II) Complexes with Antibacterial Activity

Copper(II) complex as a precursor for formation of cyano-bridged pentanuclear FeIII-CuII bimetallic assembly: Synthesis, characterization, crystal structure and antibacterial activity

Synthesis, Crystal Structures, Photophysical Properties and Antibacterial Activities of Copper(II) Complex Derived from 4-Chloro-2-{[(2,6-dimethylphenyl)imino]methyl}phenol

Synthesis, Characterization, and Antibacterial Evaluation of Copper(ii) Complexes Supported by Phenylacetic Acid Derivatives, and Diamine Ligands

Syntheses, characterizations, crystal structures, antibacterial and SOD-like activities of nickel(II) and copper(II) complexes with 2-((Z)-(4-methoxyphenylimino)methyl)-4,6-dichlorophenol

Synthesis, Crystal Structure, Antibacterial Activity And Interaction With Bsa Of Copper(Ii) Complex With Ligand N,N '-Bis(4-Chlorobenzyl) Propane-1,2-Diamine

Syntheses, Structures, Magnetic Properties and Antibacterial Activities of Two Copper(II) Azido Complexes with Varied Nuclearities Containing Symmetrical 1,3-Diammine as Chelator

Copper (II) complexes with (E)-N′(3,5-di-tert-butyl-2-hydroxybenzilidene)-2-hydroxybenzohydrazide, their bactericidal and fungicidal activity

Synthesis, characterization, molecular modeling, and antimicrobial study of copper(II) 2-chlorophenylacetohydroxamate

Investigation of the inherent characteristics of copper(II) Schiff base complexes as antimicrobial agents

Synthesis and Antibacterial Activities of Copper(Ii) with [(2-Hydroxy-3,5-diiodo-benzylidene)-amino]-acetic Acid

Syntheses, Crystal Structures and Antibacterial Activities of Copper(Ii) and Zinc(Ii) Complexes Based on (E)-4-fluoro-2-((3-morpholinopropylimino)methyl)phenol

Novel Zinc(II) and Copper(II) Complexes of 2-((2-Hydroxyethyl)amino)quinoline-3-carbaldehyde for Antibacterial and Antioxidant Activities: A Combined Experimental, DFT, and Docking Studies

Nickel(II), copper(II) and zinc(II) complexes containing symmetrical Tetradentate Schiff base ligand derived from 3,5-diiodosalicylaldehyde: Synthesis, characterization, crystal structure and antimicrobial activity

New copper(II) cyclam complexes with aminocarboxylate co-ligands: Synthesis, characterization, and in vitro antiproliferative and antibacterial studies

SYNTHESIS, CHARACTRIZATION AND ANTIBACTERIAL ACTIVITY OF SCHIFF BASES DERIVED FROM PHENYL HYDRAZINE DERIVATIVES AND THEIR Cu (II) and Zn (II) COMPLEXES